I share my investment portfolio, the instruments I use, the best timing to invest, and the strategies I apply.
Qualys, Inc. (NASDAQ: QLYS) emerges in 2026 as an exceptional value play within the cybersecurity sector. Following a 64% correction from its all-time highs, the company is trading at historically low P/E (Price-to-Earnings) multiples despite maintaining a ROIC above 25% and consistent double-digit growth. With the launch of Agent Val (agentic AI), Qualys is reaffirming […]
In April 2026, my portfolio strategy prioritizes capital preservation and fixed-income yields, allocating 42.6% to US Treasuries 10+Y. A strategic entry into Physical Gold at $4,400/oz serves as a core inflationary hedge. Despite volatility in Bitcoin ETN (-20% net profitability) and Novo Nordisk (-23%), I am maintaining high-conviction positions in Microsoft (7.8%) and Constellation Software
In March 2026, gold investment is driven by a critical need for capital preservation against unsustainable fiscal deficits, highlighted by U.S. military spending of $1 billion per day in the Iran conflict. Following a speculative peak at $5,500 and a healthy correction to $4,400, this strategic entry focuses on systemic protection. Gold serves as a
Wolters Kluwer (WKL) emerges in 2026 as a rare value opportunity. Following a 67% correction from its peaks, the company trades at a P/E ratio of 12x against an expected EPS of nearly €7 in 2028. With 83% recurring revenue and an aggressive integration of Generative AI into its “Expert Solutions,” WKL balances financial resilience
In February 2026, my February 2026 Portfolio underwent a strategic consolidation, emphasizing high-growth resilience. I increased positions in Microsoft (MSFT), Netflix (NFLX), and Constellation Software (CSU.TO), leveraging sector-specific volatility. While Bitcoin faced a -28% correction and Novo Nordisk retraced -22%, Netflix led with a +17.2% return. My strategy remains anchored in tiered entries and a
Sprouts Farmers Market (SFM) is a dominant player in the health-focused grocery niche. With $8.8 billion in revenue in 2025 and 7.3% comparable store sales growth, the company operates with solid margins and aggressive share buybacks. Currently, following a 64% technical correction from its 2025 highs, SFM trades at a forward P/E of 11x, presenting
